Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YIR043C (YIR043C) is a transmembrane protein expressed in E. coli as a recombinant product. It is annotated as a full-length protein (1–230 amino acids) with an N-terminal 10xHis-tag for purification and detection . While its biological function remains uncharacterized, it belongs to the conserved Cos protein family, often encoded in subtelomeric regions of yeast genomes . Below is a detailed analysis of its structural, production, and functional characteristics.
YIR043C is produced via bacterial expression systems in E. coli, followed by purification using nickel affinity chromatography due to its His-tag . The protein is lyophilized or stored in Tris/PBS-based buffers with 6% trehalose and 50% glycerol to enhance stability .
No Gene Ontology (GO) annotations are available for molecular function, biological process, or cellular component . This reflects insufficient experimental data to assign definitive roles.
Structural Studies: Used in SDS-PAGE for purity assessment .
Interaction Mapping: Serves as a bait in yeast two-hybrid or co-immunoprecipitation assays .
Functional Characterization: No evidence of enzymatic activity or interaction partners has been reported .
Biological Relevance: The protein’s association with the Cos family remains speculative due to the absence of functional studies .
Localization Assays: Determine subcellular localization (e.g., membrane, cytoplasm).
Phylogenetic Analysis: Compare YIR043C with homologs in other yeast species to infer evolutionary conservation.
High-Throughput Screening: Test for interactions with yeast proteins or pathways (e.g., ER stress, membrane trafficking).
| Vendor | Product Code | Form | Purity | Price Range |
|---|---|---|---|---|
| Cusabio | CSB-CF328141SVG | Lyophilized | >90% | ~€1,578 |
| Creative BioMart | RFL28971SF | Lyophilized | >90% | Inquiry-based |
| MyBioSource | MBS7059965 | Lyophilized/Liquid | ≥85% | ~$500–$1,500 |
Prices vary based on batch size and customization (e.g., tag modifications, endotoxin reduction) .
Recombinant YIR043C can be produced using several expression systems, each with distinct advantages:
E. coli expression systems: Most commonly used due to rapid growth, high protein yields, and ease of genetic manipulation. Based on the search results, E. coli has been used successfully for YIR043C expression .
Native S. cerevisiae expression: Useful for studying protein in its natural environment with appropriate post-translational modifications.
Other yeast expression systems: Pichia pastoris can be used for higher eukaryotic protein expression with proper folding.
Methodology for basic E. coli expression:
Clone the YIR043C gene into an appropriate expression vector (e.g., pGAPZαC as mentioned in search result #2)
Transform into E. coli expression strain
Induce protein expression using appropriate conditions
Harvest cells and lyse to extract protein
Purify using affinity chromatography (His-tag appears to be commonly used with YIR043C)
Although YIR043C remains largely uncharacterized, preliminary structural analysis reveals:
230 amino acid length protein
Potential membrane-associated features suggested by hydrophobic domains in its sequence
No clearly identified enzymatic domains or motifs in public databases
May contain transmembrane regions as suggested by the hydrophobic amino acid sequences ("FLIVYTSGNVDLISRFLFPVVMFFIMTR")
For researchers beginning work with YIR043C, basic structural prediction tools like PSIPRED, TMHMM, or SignalP can provide initial insights into secondary structure, transmembrane domains, and signal peptides, respectively.
Determining the function of uncharacterized proteins like YIR043C requires multiple complementary approaches:
Genetic Approaches:
Gene knockout/deletion: Generate ΔYIR043C strains to observe phenotypic changes. This can be accomplished using homologous recombination methods detailed in search result #3, which describes using PCR products for targeted gene replacement in S. cerevisiae.
Overexpression studies: Similar to the approach with other yeast genes described in search result #2, where overexpression vectors were constructed to study protein function.
Complementation tests: If knockout shows phenotype, complementation with wild-type or mutant versions can confirm specificity.
Biochemical Approaches:
Protein-protein interaction studies: Yeast two-hybrid, co-immunoprecipitation, or pull-down assays to identify interacting partners.
Subcellular localization: GFP-tagging and microscopy to determine where YIR043C localizes within the cell.
Post-translational modification analysis: Mass spectrometry to identify phosphorylation, glycosylation, or other modifications.
Comparative Genomics:
Ortholog analysis: Identify potential orthologs in other species that may have known functions.
Synteny analysis: Examine conservation of genomic context across related species.
Based on search result #3 about Sir proteins and chromatin silencing in S. cerevisiae, researchers might investigate potential connections between YIR043C and chromatin regulation:
Methodological approach:
Perform ChIP-seq experiments to determine if YIR043C associates with specific chromatin regions
Analyze genetic interactions between YIR043C and known chromatin regulators (Sir2, Sir3, Sir4)
Examine YIR043C expression changes in response to histone modifications (H4K16 acetylation, H3K79 methylation)
Test for physical interactions between YIR043C and chromatin-modifying enzymes
Researchers should specifically investigate:
If YIR043C localizes to silent chromatin regions (telomeres, HM loci)
Whether YIR043C knockout affects gene silencing
If YIR043C interacts with or influences the activity of Sir proteins
CRISPR-Cas9 System for Precise Gene Editing:
Design guide RNAs targeting YIR043C
Introduce Cas9 and guide RNA expression cassettes into yeast cells
Provide a repair template for desired modifications
Select and verify transformants
Site-Directed Mutagenesis for Structure-Function Analysis:
Identify conserved residues or predicted functional domains
Generate a panel of point mutations
Transform mutant constructs into appropriate yeast strains
Assess functional consequences of each mutation
Promoter Replacement for Controlled Expression:
Replace native YIR043C promoter with inducible promoter (e.g., GAL1)
Enable temporal control of gene expression
Monitor phenotypic changes upon induction/repression
Integration of Reporter Genes:
Fuse YIR043C to fluorescent proteins or epitope tags
Integrate constructs at native locus to maintain normal regulation
Use for real-time visualization or biochemical purification
Based on search result #1 highlighting S. cerevisiae as a model for RNA-mediated disease processes:
Methodology for RNA-focused investigation of YIR043C:
Analyze if YIR043C functions in RNA metabolism or regulation
RNA immunoprecipitation to identify bound RNAs
Analysis of RNA processing defects in YIR043C mutants
Assessment of YIR043C impact on RNA stability or translation
Develop disease-relevant models:
If YIR043C has human homologs, investigate connection to RNA-related diseases
Create yeast strains expressing human disease-associated proteins to study genetic interactions with YIR043C
Use yeast as a screening platform for compounds affecting YIR043C and related pathways
Investigate potential roles in stress response:
As noted in search result #1, yeast models are valuable for studying various stresses including neurodegeneration and aging
Test if YIR043C is involved in stress granule formation or other RNA-based stress responses
Metabolomic Analysis:
Compare metabolite profiles between wild-type and ΔYIR043C strains using:
Liquid chromatography-mass spectrometry (LC-MS)
Gas chromatography-mass spectrometry (GC-MS)
Nuclear magnetic resonance (NMR) spectroscopy
Flux analysis using stable isotope labeling:
Culture yeast with 13C-labeled carbon sources
Track isotope incorporation into metabolites
Identify metabolic pathways affected by YIR043C
Integration with Transcriptomic and Proteomic Data:
Perform RNA-Seq on ΔYIR043C strains to identify gene expression changes
Conduct proteomics analysis to detect altered protein levels
Integrate multi-omics data to identify affected pathways
Enzyme Assay Development:
Test if YIR043C has enzymatic activity:
Develop in vitro assays with purified protein
Screen against potential substrates
Measure kinetic parameters
Expression Optimization:
| Parameter | Recommended Conditions | Alternatives to Test |
|---|---|---|
| Expression System | E. coli BL21(DE3) | Rosetta(DE3), Arctic Express |
| Expression Vector | pET with His-tag | GST fusion, MBP fusion |
| Induction | 0.5 mM IPTG, 18°C, 16h | Auto-induction media |
| Media | LB with glucose | Terrific Broth, Minimal media |
| Cell lysis | Sonication in Tris buffer | French press, detergent lysis |
Purification Strategy:
Immobilized metal affinity chromatography (IMAC) using His-tag
Size exclusion chromatography to ensure monodispersity
Ion exchange chromatography for final polishing
Stability Screening:
Test multiple buffer conditions (varying pH, salt concentration, additives) using differential scanning fluorimetry to identify conditions that maximize protein stability.
Structural Analysis Approaches:
X-ray crystallography: Screen crystallization conditions using commercial kits
Cryo-EM: For potential protein complexes
NMR: For dynamic regions or if crystallization proves challenging
When facing contradictory data regarding YIR043C function, a systematic approach is essential:
Methodological framework for resolving contradictions:
Replicate original experiments with careful attention to:
Strain background variations (S288C vs. other laboratory strains)
Growth conditions and media composition
Precise experimental protocols and reagents
Perform epistasis analysis:
Create double mutants between YIR043C and genes in suspected pathways
Analyze genetic interactions (synthetic lethality, suppression)
Compare phenotypic outcomes to single mutants
Use orthogonal techniques to confirm findings:
If functional data came from genetic studies, confirm with biochemical approaches
If protein interaction data seems contradictory, use multiple interaction methods
Implement CRISPR interference or other acute depletion methods alongside knockout studies
Control for indirect effects:
Test for general stress responses
Measure growth rates to account for secondary effects
Use time-course experiments to distinguish primary from secondary effects
Consider post-translational modifications:
Examine if contradictory results might be explained by different modification states
Test if function depends on specific conditions that might affect modifications
Design Principles for Genetic Interaction Screens:
Selection of appropriate screening method:
Synthetic genetic array (SGA) analysis: Systematic creation of double mutants
Multicopy suppressor screens: Identify genes that rescue YIR043C mutant phenotypes
CRISPR-based screens: Higher precision for partial loss-of-function studies
Control design:
Include positive controls (genes known to interact with similar pathways)
Include negative controls (genes in unrelated pathways)
Use multiple alleles of YIR043C (null, hypomorphic, tagged versions)
Growth conditions:
Test multiple environmental conditions (temperature, carbon source, stress)
Include conditions that might reveal conditional phenotypes
Data analysis framework:
Define appropriate statistical thresholds for interactions
Use computational methods to identify enriched pathways and processes
Compare results to existing genetic interaction networks
Validation strategies:
Secondary screens with orthogonal methods
Detailed phenotypic characterization of top hits
Biochemical validation of physical interactions
Methodological approach for evolutionary studies:
Comprehensive sequence analysis:
Perform sensitive sequence searches (PSI-BLAST, HHpred) to identify distant homologs
Analyze sequence conservation patterns across fungal species
Create multiple sequence alignments to identify conserved residues
Structural prediction analysis:
Use AlphaFold or RoseTTAFold to predict YIR043C structure
Compare predicted structural features across species
Identify potential functional domains based on structural conservation
Functional complementation experiments:
Clone potential homologs from other species
Test if they can complement YIR043C deletion in S. cerevisiae
Analyze domain-swapping constructs to identify functionally conserved regions
Comparative genomics:
Analyze genomic context of YIR043C homologs across species
Identify conserved synteny or operon-like arrangements
Examine co-evolution with interacting partners
Comparative expression analysis:
Compare expression patterns of homologs across species
Identify conserved regulatory elements
Test if expression is responsive to similar conditions across species